Morita–Baylis–Hillman adducts derived from thymol: synthesis, in silico studies and biological activity against Giardia lamblia
Autor: | Abrahão Alves de Oliveira Filho, Gabriel Corrêa Veríssimo, Andressa Brito Lira, Elaine M. Souza-Fagundes, Margareth de Fátima Formiga Melo Diniz, Fábio P.L. Silva, Mário L. A. A. Vasconcellos, Maria Carmen Aires Gomes, Claudio G. Lima-Junior, Francisco José Seixas Xavier, Fernanda S. de S. Saraiva, Aleff C. Castro |
---|---|
Rok vydání: | 2021 |
Předmět: |
Antiparasitic
medicine.drug_class Organic Chemistry Biological activity General Medicine DABCO medicine.disease_cause Catalysis Adduct Bioavailability Inorganic Chemistry chemistry.chemical_compound chemistry Drug Discovery medicine Giardia lamblia Organic chemistry Physical and Theoretical Chemistry Cytotoxicity Molecular Biology Thymol Information Systems |
Zdroj: | Molecular Diversity. 26:1969-1982 |
ISSN: | 1573-501X 1381-1991 |
Popis: | Giardiasis is a neglected disease, and there is a need for new molecules with less side effects and better activity against resistant strains. This work describes the evaluation of the giardicidal activity of thymol derivatives produced from the Morita–Baylis–Hillman reaction. Thymol acrylate was reacted with different aromatic aldehydes, using 1,4-diazabicyclo[2.2.2]octane (DABCO) as a catalyst. Eleven adducts (8 of them unpublished) with yields between 58 and 80% were obtained from this reaction, which were adequately characterized. The in silico prediction showed theoretical bioavailability after oral administration as well as antiparasitic activity against Giardia lamblia. Compound 4 showed better biological activity against G. lamblia. In addition to presenting antigiardial activity 24 times better than thymol, this MBHA was obtained in a short reaction time (3 h) with a yield (80%) superior to the other investigated molecules. The molecule was more active than the precursors (thymol and MBHA 12) and did not show cytotoxicity against HEK-293 or HT-29 cells. In conclusion, this study presents a new class of drugs with better antigiardial activity in relation to thymol, acting as a basis for the synthesis of new bioactive molecules. Molecular hybridization technique combined with the Morita–Baylis–Hillman reaction provided new thymol derivatives with giardicidal activity superior to the precursor molecules. |
Databáze: | OpenAIRE |
Externí odkaz: |